Evidence map›Paper›PMID 40294118›Full record

ArticleVeterinary medicine and science2025

Evidence of SARS-CoV-2 Exposure in Cats and Dogs From Households in Romania and Long-Term Specific Seroconversion in Cats.

Luanda Elena Oslobanu, Luciana Alexandra Crivei, Gheorghe Savuta, Laro Gómez-Marcos, Pablo Nogales-Altozano, José M Rojas, Noemí Sevilla

Abstract read
In one paragraph

Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luanda Elena OslobanuFaculty of Veterinary Medicine, Regional Center of Advanced Research for Emerging Diseases, Zoonoses and Food Safety, "Ion Ionescu de la Brad" Iasi University of Life Sciences, Iași, Romania.ORCID 0000-0003-1611-1381
Luciana Alexandra CriveiFaculty of Veterinary Medicine, Regional Center of Advanced Research for Emerging Diseases, Zoonoses and Food Safety, "Ion Ionescu de la Brad" Iasi University of Life Sciences, Iași, Romania.
Gheorghe SavutaFaculty of Veterinary Medicine, Regional Center of Advanced Research for Emerging Diseases, Zoonoses and Food Safety, "Ion Ionescu de la Brad" Iasi University of Life Sciences, Iași, Romania.
Laro Gómez-MarcosCentro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (CISA-INIA-CSIC), Valdeolmos, Madrid, Spain.
Pablo Nogales-AltozanoCentro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (CISA-INIA-CSIC), Valdeolmos, Madrid, Spain.
José M RojasCentro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (CISA-INIA-CSIC), Valdeolmos, Madrid, Spain.
Noemí SevillaCentro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (CISA-INIA-CSIC), Valdeolmos, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic underscored the need to understand the zoonotic transmission of pathogens. SARS-CoV-2 has been reported to be transmitted from humans to pets, including cats and dogs, particularly after close contact with infected individuals. Studies have shown that cats are more susceptible to natural infection and can transmit the virus to other cats and humans. The zoonotic transmission route represents a risk for animal health workers. Despite global reports, data from Romania remain sparse. This study aimed to evaluate the presence of SARS-CoV-2 specific antibodies in household dogs and cats in Romania during the COVID-19 pandemic.

methodsThe study was conducted at a veterinary clinic in Iasi City, Romania, from March 2020 to December 2022. Blood samples were collected from 84 cats and 82 dogs that had been in contact with COVID-19-positive owners. Plasma samples were tested for anti-SARS-CoV-2 antibodies using an ELISA test, followed by confirmation with a seroneutralisation (SN) assay. The SN assay used the SARS-CoV-2 MAD6 strain and Omicron strain to determine neutralising antibody titers.

resultsELISA testing showed a seroprevalence of 9.5% in cats and 11% in dogs. Further SN assay testing confirmed SARS-CoV-2 specific antibodies in 9.4% of cats and 2.4% of dogs. One cat maintained antibodies for over a year, though with reduced titers. Most cats' antibodies did not cross-react with the Omicron strain, indicating limited cross-reactivity. The study highlighted higher seroprevalence and antibody titers in cats compared to dogs, likely due to more efficient viral replication in cats.

conclusionsThis study provides the first serological evidence of SARS-CoV-2 exposure in household pets during the pandemic in Romania, with findings suggesting cats are more susceptible to infection from their owners than dogs. The cats that were living in households in one area of the city were prone to be infected with SARS-CoV-2 from their owners and high levels of seroconversion were detected. These results align with global reports, demonstrating that cats are particularly susceptible to SARS-CoV-2 when living with infected owners.

Indexed as

Cat DiseasesCOVID-19Dog DiseasesSARS-CoV-2SeroconversionAnimalsAntibodies, ViralCatsDogsFemaleMaleRomaniaSeroepidemiologic StudiesAntibodies, Virallong term seroconversion in catsRomaniaSARS‐CoV‐2 in petsseroneutralisationzooanthroponotic transmission

Identifiers

PMID40294118
PMCPMC12036693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.